Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of QNTM will decline by -32.05% over the next 2 Weeks and hit $2.11 by Monday, April 6, 2026. In that time frame, QNTM's share price is expected to range between $1.72 and $2.48.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 6, 2026 | 1.72 | 2.11 | 2.48 |
| Apr 3, 2026 | 1.71 | 2.09 | 2.42 |
| Apr 2, 2026 | 1.75 | 2.09 | 2.44 |
| Apr 1, 2026 | 1.65 | 2.02 | 2.39 |
| Mar 31, 2026 | 1.90 | 2.26 | 2.65 |
| Mar 30, 2026 | 2.03 | 2.39 | 2.79 |
| Mar 27, 2026 | 2.00 | 2.37 | 2.73 |
| Mar 26, 2026 | 2.02 | 2.37 | 2.76 |
| Mar 25, 2026 | 1.94 | 2.31 | 2.69 |
| Mar 24, 2026 | 2.19 | 2.55 | 2.93 |
QNTM shares rose +52.58% in Tuesday, March 24, 2026's trading session, rising from a previous close of $3.10 to move at $4.73. The stock demonstrated notable intraday movement (see QNTM's key stats for a full breakdown), fluctuating between $3.01 and $4.82, a +60.13% trading range. While recent weeks have seen some volatility, QNTM has managed to secure a +125.24% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.74M shares changing hands, 1.38M more than the previous session. This amounted to $12.98M in total market activity.
Will QNTM Continue Its Downward Trend?
According to analyst ratings and projections for QNTM, Quantum BioPharma Ltd. shares are anticipated to decrease by -91.06%, potentially reaching $2.48 per share by April 6, 2026. Short-term technical indicators for QNTM currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the QNTM stock forecast, now is not the best time to buy QNTM stock because its current trading price is +124.53% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on QNTM covering social and institutional perspectives.
QNTM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into QNTM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.28% to 75.91%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 45.41%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.98%, maintains a neutral outlook for the long term. Insights into QNTM's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Quantum BioPharma Short-Term Forecasts
QNTM Forecast For Next 5 Days
Our algorithm anticipates Quantum BioPharma (QNTM) stock could hit $2.34 by Mar 31, 2026. This represents a -50.43% rise from today's price, following a +3.74% change over the past five days.
QNTM Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Quantum BioPharma Ltd. (QNTM) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.16, which would mean a -54.33% decrease from the current price of $4.73. Projections for this period range from a high of $3.21 to a low of $1.39.
QNTM Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Quantum BioPharma's price over the next three months point to a drop. QNTM stock is expected to peak at $4.62 on Apr 08, 2026 before potentially dipping to $0.00 on Jun 23, 2026. On average, QNTM is likely to trade around $1.88 in the coming 90 days.
Quantum BioPharma Stock Forecast 2025
Based on our predictive models, Quantum BioPharma (QNTM) is expected to trade between $0.00 and $4.62 throughout 2026. This would result in an average price of $0.95, potentially offering investors a -79.92% return from current levels.
Quantum BioPharma Ltd. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Quantum BioPharma Ltd. (QNTM) is positioned to show a strong performance in March 2026. The price is predicted to move between $1.74 and $4.61, settling at an average of $3.19. This could translate to a -32.56% loss.
April 2026
Based on current market signals, Quantum BioPharma Ltd. is projected to trend april 2026. We forecast a trading range from $0.00 to $4.62, with a likely average price of $2.51. Investors could expect a potential return of -46.93%.
May 2026
Our predictive algorithms indicate Quantum BioPharma Ltd. stock may see a shift in May 2026. The expected range spans $0.00–$2.87, with an average target of $1.17. This represents a cautious outlook and a possible loss of -75.26%.
June 2026
Analyzing established trends, Quantum BioPharma Ltd. looks set to move in June 2026. Projections place the stock between $0.00 and $2.96, averaging around $1.45. This suggests a -69.34% loss from current levels.
July 2026
Market indicators suggest Quantum BioPharma Ltd. could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $2.25, with a midpoint forecast of $0.65. The stock might deliver a -86.26% loss.
August 2026
Forecasting for August 2026, models estimate that Quantum BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.36, averaging $0.79. This signals a cautious trajectory with potential returns around -83.30%.
September 2026
According to our latest forecast models, Quantum BioPharma Ltd. (QNTM) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $1.93, settling at an average of $0.48. This could translate to a -89.85% loss.
October 2026
Based on current market signals, Quantum BioPharma Ltd. is projected to trend october 2026. We forecast a trading range from $0.00 to $1.74, with a likely average price of $0.42. Investors could expect a potential return of -91.12%.
November 2026
Our predictive algorithms indicate Quantum BioPharma Ltd. stock may see a shift in November 2026. The expected range spans $0.00–$1.84, with an average target of $0.39. This represents a cautious outlook and a possible loss of -91.75%.
December 2026
Analyzing established trends, Quantum BioPharma Ltd. looks set to move in December 2026. Projections place the stock between $0.00 and $1.56, averaging around $0.15. This suggests a -96.83% loss from current levels.
January 2027
Market indicators suggest Quantum BioPharma Ltd. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $1.49, with a midpoint forecast of $0.15. The stock might deliver a -96.83% loss.
February 2027
Forecasting for February 2027, models estimate that Quantum BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.25, averaging $0.13. This signals a cautious trajectory with potential returns around -97.25%.
March 2027
According to our latest forecast models, Quantum BioPharma Ltd. (QNTM) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.79, settling at an average of $0.15. This could translate to a -96.83% loss.
QNTM's history of dividends and stock splits also plays a role in long-term investor confidence.

